Both AST and ALT levels are increased to some extent in almost all liver diseases due to hepatocellular necrosis, including NAFLD, cirrhosis, non-alcoholic steatohepatitis (NASH), etc. [24]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.